SoVote

Decentralized Democracy

House Hansard - 139

44th Parl. 1st Sess.
December 1, 2022 10:00AM
Context: House Hansard - 139 - Dec/1/22
Ms. Annie Koutrakis (Vimy, Lib.)
  • Dec/1/22 2:05:27 p.m.
  • Watch
Mr. Speaker, I rise today to recognize the hard work and dedication of Dr. Lucy Gilbert and her team, who developed DOvEEgene, the world's first genomic uterine cancer screening test, at the McGill University Health Centre. Ovarian and endometrial cancers are the fourth most common cause of cancer deaths in Canadian women. Deaths related to endometrial cancers are rising while the five-year survival of ovarian cancer patients is below 50%. However, there is hope. DOvEEgene detects and diagnoses these cancers early, when they are microscopic and have not spread. Early diagnosis means potential cure rates of over 80%. This work adds to Canada’s history of scientific excellence. It is a history that too often goes unsupported. We cannot miss this chance to capitalize on this scientific achievement, because it will save countless women's lives in Canada and throughout the world.
146 words
  • Hear!
  • Rabble!
  • star_border